Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 9 of 9 publications.

Poulos C, Ng X, Mansfield C, Rosenberg S, Peay H, Lee J, Irony T, Ho M. Logical soundness in a discrete choice experiment study of benefit risk preferences. Presented at the ISPOR 2022 Conference; May 15, 2022. Washington, DC. [abstract] Value Health. 2022 Jun; 25(6 S1).

Ng X, Stothers S, Mansfield C, Poulos C, Peay H, Lee TS, Irony T, Ho M. Adaptation of the Western Ontario McMaster Universities (WOMAC) osteoarthritis index for use in a patient preference study to inform regulatory decision-making. Poster presented at the 2021 SMDM Virtual Annual Meeting; October 19, 2021.

Myers K, Klein K, Mansfield C, Poulos C. A review of the use of comprehension questions in health preference studies. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S319-20. doi: 10.1016/j.jval.2020.04.1189

Mansfield C, Poulos C, Ho M. Using patient-reported outcomes in the design of stated preference surveys: challenges and opportunities. Presented at the 2020 ISPOR Virtual Conference; May 2020.

Mansfield C, Poulos C, Boeri M, Hauber B. Performance of a comprehension question in discrete-choice experiment surveys (DCE). Poster presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).

Bullok KE, Hauber AB, Mansfield CA, DiSantostefano RL, Poulos C. Patient preferences: using conjoint analysis and stated preferences in drug development and regulatory decision making. Presented at the DIA 2019 Global Annual Meeting; June 23, 2019. San Diego, CA.

Mansfield CA, Sikirica M, Pugh A, Poulos C, Martin AA, Ruiz Moran L, Morano Larragueta R. Patient preferences for attributes of type 2 diabetes mellitus (T2DM) treatments in Spain. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Mansfield CA, Poulos C, Hackshaw MD, Pugh AL, Jobanputra M. Patient preferences for first-line maintenance treatments for ovarian cancer. Presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.